05/08/2024
3:15 PM | Olema Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
4:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
2:25 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
4:10 PM | Olema Pharmaceuticals (Filer)
| Form DEFA14A | |
04/26/2024
4:15 PM | Olema Pharmaceuticals (Filer)
| Form ARS | |
03/29/2024
4:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/28/2024
10:02 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
3:31 PM | Deep Track Capital, LP (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G | |
03/20/2024
4:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:31 PM | Olema Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2024
3:15 PM | Olema Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
4:36 PM | Olema Pharmaceuticals (Issuer)
RAPPAPORT ANDREW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
1:26 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
11:53 AM | Kynam Capital Management, LP (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
4:16 PM | Olema Pharmaceuticals (Filer)
| Form 424B3 | |
02/12/2024
11:21 AM | JANUS HENDERSON GROUP PLC (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/11/2024
11:15 PM | Olema Pharmaceuticals (Filer)
| Form EFFECT | |
02/05/2024
4:30 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
2:24 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
1:58 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G | |
01/29/2024
6:30 AM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
6:30 AM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
8:07 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:18 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:25 PM | Olema Pharmaceuticals (Filer)
| Form 424B5 | |
01/05/2024
4:26 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
4:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:30 PM | Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:55 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:55 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
3:19 PM | Asefaw Senai (Reporting)
Olema Pharmaceuticals (Issuer)
Paradigm BioCapital Advisors GP LLC (Reporting)
Paradigm Biocapital Advisors LP (Reporting)
Paradigm BioCapital International Fund Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 3/A | |
12/07/2023
7:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
6:48 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The 2024 Gold Rush: Unleashing Market Potential (Ad) Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. |
12/05/2023
4:15 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
4:15 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
9:20 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
6:00 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
2:25 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
2:04 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
2:12 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
1:35 PM | Olema Pharmaceuticals (Subject)
Zojwalla Naseem (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
1:42 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
2:11 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
2:16 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
1:49 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
1:52 PM | Olema Pharmaceuticals (Subject)
Zojwalla Naseem (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
4:30 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
8:39 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:53 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
7:50 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:46 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:21 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
3:49 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2023
9:38 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2023
6:45 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
3:46 PM | Olema Pharmaceuticals (Filer)
| Form 8-K/A | |
10/17/2023
3:42 PM | Garland J. Scott (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2023
3:43 PM | Garland J. Scott (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
6:33 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
6:17 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
10:05 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/21/2023
4:12 PM | Asefaw Senai (Reporting)
Olema Pharmaceuticals (Issuer)
Paradigm BioCapital Advisors GP LLC (Reporting)
Paradigm Biocapital Advisors LP (Reporting)
Paradigm BioCapital International Fund Ltd. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
3:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/14/2023
3:25 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:14 PM | Olema Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/13/2023
4:22 PM | Olema Pharmaceuticals (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G/A | |
09/05/2023
8:08 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:05 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4/A | |
09/05/2023
12:42 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
6:39 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
3:37 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/20/2023
11:22 AM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2023
1:54 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023
3:36 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2023
3:40 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023
3:49 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
6:14 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Olema Pharmaceuticals (Issuer)
RAPPAPORT ANDREW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | BUTITTA CYNTHIA M (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Did You Get Your Free Bitcoin Yet? (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
06/21/2023
4:00 PM | Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Hrustanovic Gorjan (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Horning Sandra (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Larson Yi (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | CLARK IAN T (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:31 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:23 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
3:28 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
4:53 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
